<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-26T20:26:51Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/7083" metadataPrefix="dim">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/7083</identifier><datestamp>2021-06-18T09:33:23Z</datestamp><setSpec>com_10324_38</setSpec><setSpec>col_10324_787</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="es" authority="2995a4e4-95cd-4665-8173-164de7020fa1" confidence="500" orcid_id="">Carvajal García-Pando, Alfonso</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="9ed38ae7-a750-43bb-96c0-af3b836ce421" confidence="500" orcid_id="">Justafort, Pierre</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="editor" lang="es" authority="EDUVA60" confidence="500" orcid_id="">Universidad de Valladolid. Facultad de Medicina</dim:field>
<dim:field mdschema="dc" element="date" qualifier="accessioned">2014-11-12T08:54:00Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="available">2014-11-12T08:54:00Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="issued">2014</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="uri">http://uvadoc.uva.es/handle/10324/7083</dim:field>
<dim:field mdschema="dc" element="description" qualifier="abstract" lang="es">Conocer si los bisfosfonatos se asocian con alteraciones musculoesqueléticas. 1. Conocer la fuerza de la asociación entre la exposición a bisfosfonatos y la aparición de alteraciones musculoesqueléticas.&#xd;
2. Conocer la influencia de ciertos factores pronósticos en la aparición de alteraciones musculoesqueléticas asociadas a bisfosfonatos.</dim:field>
<dim:field mdschema="dc" element="description" qualifier="sponsorship" lang="es">Departamento de Anatomía y Radiología</dim:field>
<dim:field mdschema="dc" element="format" qualifier="mimetype" lang="es">application/pdf</dim:field>
<dim:field mdschema="dc" element="language" qualifier="iso" lang="es">spa</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="accessRights" lang="es">info:eu-repo/semantics/openAccess</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="uri">http://creativecommons.org/licenses/by-nc-nd/4.0/</dim:field>
<dim:field mdschema="dc" element="rights">Attribution-NonCommercial-NoDerivatives 4.0 International</dim:field>
<dim:field mdschema="dc" element="subject" lang="es">Bifosfonatos</dim:field>
<dim:field mdschema="dc" element="subject">Músculos - Enfermedades</dim:field>
<dim:field mdschema="dc" element="title" lang="es">Alteraciones articulares asociadas a los bisfosfonatos</dim:field>
<dim:field mdschema="dc" element="type" lang="es">info:eu-repo/semantics/doctoralThesis</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>